EUObserver reports that the European Medicines Agency has reversed its long-held stance on releasing studies on drug side effects after pressure from the European Ombudsman. The London-based agency, which evaluates drugs in the EU, on Wednesday (11 August) said that it would issue data on anti-acne medication Roaccutane produced by pharma giant Roche in the coming weeks.
Read more here: http://euobserver.com/9/30613/?rk=1
Upcoming Industry Meetings and Webinars, January 1 - March 31, 2026
-
Here are the industry events and webinars I'm aware of for January 1 -
March 31, 2026. I don't have anything to do with any of these from a
planning pers...
6 hours ago
No comments:
Post a Comment